Lonza
Daniel Palmacci is a highly experienced individual in the pharmaceutical industry, currently serving as the President Cell and Gene Division at Lonza. With a background in Chemistry and Chemical Engineering, Daniel has held various leadership positions at companies such as MorphoSys, Novartis, and Bayer. Daniel's expertise includes global manufacturing operations, supply chain management, technical operations, and portfolio management. Daniel has a strong track record of successful project management and strategic decision-making in the biopharmaceuticals sector.
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.